Apremilast Impurity 43 | CAS 1255909-25-1 - Request Quote
Apremilast Impurity 43
| SZ CAT No: | SZ-A051068 |
| CAS No | 1255909-25-1 |
| Mol.F. | C11H17NO4S |
| Mol.Wt. | 259.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Apremilast Impurity 43 is chemically 1-(3,4-Dimethoxyphenyl)-2-(methylsulfonyl)ethan-1-amine. Apremilast Impurity 43 is supplied with detailed characterization data compliant with regulatory guideline. Apremilast Impurity 43 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apremilast.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1255909-25-1
Purchase 1255909-25-1
Order 1255909-25-1
Enquire 1255909-25-1
price of 1255909-25-1
1255909-25-1 Supplier
1255909-25-1 Manufacturer
1255909-25-1 Exporter
buy high quality Apremilast Impurity 43
Purchase Apremilast Impurity 43
Apremilast Impurity 43 suppliers
Apremilast Impurity 43 manufacturers
Apremilast Impurity 43 price
Order Apremilast Impurity 43
Enquire Apremilast Impurity 43
Apremilast Impurity 43 cost
Apremilast Impurity 43 Supplier
Apremilast Impurity 43 Distributor
Apremilast Impurity 43 for Method Validation
Apremilast Reference Standard
Apremilast Impurity 43 for ANDA Filing
Apremilast Impurity 43 for Forced Degradation Studies
Apremilast Impurity 43 Identification Standards
Apremilast Impurity 43 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.